Radioactive carcinogens have provided most of our present knowledge about the chemistry of interactions between carcinogens and biological systems. The requirement of radioactive carcinogens has restricted carcinogen-DNA binding studies to chemicals that are readily available in isotopically labeled form, i.e., a minute fraction of all potentially mutagenic or carcinogenic chemicals. To extend the scope of carcinogen-DNA binding studies, an alternative method, which does not require radioactive test chemicals, has been developed. In this approach, radioactivity (32P) is being incorporated into DNA constituents by polynucleotide kinase-catalyzed [3PIphosphate transfer from [y-32P]ATP after exposure of the DNA in vitro or in vivo to a nonradioactive, covalently binding chemical, and evidence for the alteration of DNA nucleotides is provided by the appearance of extra spots on autoradiograms of thin-layer chromatograms of digests of the chemically modified DNA. Quantitation of adduct levels is accomplished by scintillation counting. The sensitivity of the technique depends on the experimental conditions for 32P-labeling and on the chemical structure of the adducts. Greater sensitivity may be achieved if adducts can be separated as a class from the normal nucleotides. This is the case for an estimated 80% of all carcinogens, giving rise to bulky and/or aromatic substituents in DNA. Under the present conditions, one such adduct in 109 to 1010 normal nucleotides can be detected. A total of approximately 80 compounds has been studied thus far. Binding to DNA of rodent tissues was readily detected by the "2P-postlabeling assay for all known carcinogens among these compounds, and adducts were detected in DNA from human placenta of smokers.
Introduction
Any chemical capable of forming covalent bonds with DNA of somatic and reproductive mammalian cells in vivo is a potential mutagen, carcinogen, and teratogen. Since such genotoxic chemicals may be of natural or man-made origin, exposure to them cannot be completely eliminated, but human contact with them must be minimized. Methods enabling one to detect and quantify DNA binding potential of chemicals directly in vivo should be of great value in the detection of gene-altering chemicals in the environment, provided they can be applied to a large number of chemicals of diverse structure and their sensitivity is sufficient to detect low DNAbinding activities. Because covalent DNA binding of chemicals in experimental animals may range from one adduct in 103 normal nucleotides to one adduct in 109 to 1010 nucleotides, such methods should ideally be capable As pointed out by Lutz (1, 2) , the covalent binding index (CBI), defined as ,umole of chemical bound per mole of DNA nucleotide/millimole of chemical administered per kilogram body weight of animal, exhibits a good quantitative correlation with the hepatocarcinogenic potency of chemicals of diverse structure. Therefore, methods for the analysis of adducts in DNA should not only detect but also quantitate DNA binding. The subject of this paper is to review our recent efforts to develop such an ultrasensitive method involving 32p_ postlabeling of adducts (3) (4) (5) (6) and to describe results obtained by applying the method to a number of genotoxic chemicals of diverse structure.
Materials and Methods
The sources of materials used in the 32P-postlabeling procedure as well as safety precautions and chromatographic and autoradiographic procedures have been re- Figure 1 . Under the conditions of excess ATP (4, 6) , the relative adduct labeling 
Results
For the 32P-postlabeling scheme to serve as a test for the capacity of chemicals to bind to DNA, it should be applicable to most or all covalently binding chemicals; thus a major question to be answered in the initial phase ofthe development ofthe method was whether a greater number of adducts of diverse structure was amenable to 32P-postlabeling by T4 polynucleotide kinase-catalyzed phosphorylation. We have thus far studied a total of ca. 80 chemicals comprising arylamines and derivatives, azo compounds, nitroaromatics, polycyclic aromatic hydrocarbons, heterocyclic polynuclear compounds, alkenylbenzenes, mycotoxins, and methylating agents. In every case, 32P-labeling of carcinogen-DNA derivatives could be readily detected, indicating that the 32P-postlabeling method can be applied to a very large number of chemically diverse adducts. Many of the compounds studied are listed in Table 1 . bisphosphates (I). 32P-labeling of nucleotides may be conducted under standard conditions (employing excess ATP over DNA-P) or under adduct intensification (ATP-deficient) conditions, as shown in Figure 2 . The latter conditions afford the preferential labeling of many aromatic carcinogen-DNA adducts, which results in a greatly increased sensitivity of adduct detection (7) . In addition to PEI-cellulose TLC, reversed-phase TLC on octadecylsilane (C18) layers was found to separate the normal nucleotides from the adduct nucleotides (6) . To remove the labeled normal nucleotides and resolve the [32P]adducts, a four-directional (4-D) anion-exchange PEI-cellulose TLC system was developed (Fig. 3) . In this procedure, freshly prepared labeled digest (14) (15) (16) (17) (18) ,uCi/,L) is being applied slowly to the origin (Fig. 3,  OR) sample application without drying of the origin area.
Conditions for the various developments have been indicated in the legend of Figure 3 . This procedure has been applied successfully to aromatic carcinogens having two to six aromatic rings; in the case of less aromatic carcinogens (such as alkenylbenzenes, sterigmatocystin, and aflatoxin B1), removal of normal nucleotides from the adducts was best accomplished by C18 reversed-phase TLC (see Fig. 4 ). The lower limit of adduct detection was found to be 1 adduct in (3.5-6) x 107 nucleotides for the standard 4-D PEI-cellulose TLC procedure, while one adduct in about 105 nucleotides could be detected if removal of normal nucleotides from the adduct nucleotides was carried out by reversed-phase TLC, the increase in sensitivity being due to reduced background radioactivity (6 Some examples of applications of the postlabeling method follow; additional examples have been described (4-6). The method was applied to skin DNA from mice treated topically with the polycyclic aromatic hydrocarbons benzo(a)pyrene (BP), 7,12-dimethylbenz(a)-anthracene (DMBA), and 3-methylcholanthrene (MC), respectively. As shown by autoradiography (Fig. 5) , a large number of 32P-labeled MC-DNA adducts was detected in digests of DNA obtained from mouse skin at several time points after carcinogen treatment. Four of these adducts (spots 4, 7, 9, and 10) were highly persistent (Figs. 5c, 5d ). As shown in Figure 6 , substantial removal of MC-DNA adducts occurred during the first 2 weeks after carcinogen application, while adducts remaining thereafter underwent little change. Analogous results were reported for BP-DNA and DMBA-DNA adducts (5) , with some adducts persisting in mouse epidermis and dermis for about 1 year after a single topical carcinogen application (7) . These results raise the possibility that the persistent adducts occupy specific genomic sites in quiescent cells where they may not be amenable to repair because of localized conformational alterations of DNA or shielding by associated proteins.
In Figure 7 , application of the 3P-postlabeling method to rat liver DNA after exposure in vivo to the mycotoxins aflatoxin B, and sterigmatocystin, respectively, is illustrated. These compounds are known potent hepatocarcinogens (8, 9) , and in vivo DNA binding of aflatoxin B1 has been studied extensively (10, 11) , but no such data were available for sterigmatocystin-DNA binding in vivo. Our studies on these mycotoxins revealed that the adducts seen on 32P-labeled fingerprints (Fig. 7) were mostly oligo-(di-and tri-)nucleotides, because the enzymatic digestion under standard conditions (4) of DNA containing such adducts led to the formation of oligonucleotides (mostly di-and trinucleotides) rather than to the formation of the usual mononucleotide adducts (12) . Sterigmatocystin-DNA adducts were detectable in rat liver DNA as late as 3.5 6 
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Days after treatment ,uL acetone each. Digest of DNA from control mice that had received acetone only did not give any of the numbered spots. Separation was by the standard procedure (Fig. 3) , and spots were visualized by autoradiography. months after injection of a single dose (9 mg/kg) of sterigmatocystin to male Fischer rats (12) . When equal doses were compared, sterigmatocystin led to an approximately 10 times lower level of DNA modification than did aflatoxin B1, in accord with a close to 10-fold lower carcinogenic potency of the former compound as compared to the latter (9) . We have applied the 32P-postlabeling test to the analysis of the binding of a series of carcinogenic and noncarcinogenic alkenylbenzenes (13) to adult (14) and newborn (15) mouse liver DNA. Extensive carcinogenicity studies by Miller et al. (13) in mice had shown that, among these compounds, only three, i.e., safrole, estragole, and methyleugenol, were hepatocarcinogenic in the test animals. We wished to ascertain by 32P-postlabeling assay whether a correlation existed between the DNA-binding activities of these compounds in mouse liver and their biological activity or lack of activity in assays for carcinogenicity in this organ. As illustrated in Figure 8 , our results showed that the known hepatocarcinogens exhibited the strongest binding to mouse liver DNA 24 hr after IP administration of a 10-mg dose (one adduct in 10,000-15,000 DNA nucleotides or 200-300 fmole adduct/,g DNA), while the other structurally related alkenylbenzenes, except eugenol, all bound to mouse liver DNA also. but at lower levels.
In Table 1 , most of the compounds we have studied thus far are listed, together with the tissues investigated, the number of adducts detected for each compound, and an estimation of total adduct level for each compound. With the exception of anthracene, pyrene, and perylene, all the compounds gave rise to 32P-labeled adducts at the levels indicated. It appears noteworthy that within the group of polycyclic aromatic hydrocarbons, a good correlation was observed between the carcinogenic potency of individual compounds for mouse skin (16, 17) and their binding levels to mouse skin DNA. In particular, we failed to detect DNA binding of the noncarcinogens anthracene, pyrene, and perylene (at a sensitivity of detection of one adduct in about 109 nucleotides), while the strong carcinogens BP, DMBA, and MC, exhibited the highest levels of DNA binding.
The illustrations provided in this article and elsewhere (4) (5) (6) demonstrate that each compound gives rise to a characteristic fingerprint of 32P-labeled adduct derivatives on PEI-cellulose maps. Therefore, it is possible on the basis of such fingerprints, to identify the carcinogen to which the particular DNA had been exposed in vivo.
The adduct intensification version of the 32P-postla- (14) These results demonstrate that the 32P-postlabeling test is capable of detecting weakly genotoxic compounds, which either are not carcinogenic or whose carcinogenicity is not readily shown in animal bioassays. A compound such as myristicin, which binds only ca. 4 fold less than the structurally related hepatocarcinogen safrole to mouse liver DNA (14) , but has not been shown to induce cancer in mouse bioassays (13) Our work on the development and applications of the 32P-postlabeling method for adduct analysis was supported by USPHS grants CA 25590, CA 30606, CA 32157, and CA 10893 (P6), awarded by the National Cancer Institute. We wish to thank a great number of colleagues and friends-too numerous to be named here-who have greatly contributed to this work by encouraging us during the development of the method and/or by providing samples used in the standardization of experimental conditions.
